ArticleAdvances in radiation oncology2024

Combining Obinutuzumab With Radiation for Refractory DLBCL: Retrospective Safety and Efficacy Analysis.

Brett A Morris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.